日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Local human impacts disrupt depth-dependent zonation of tropical reef fish communities

人类活动对热带珊瑚礁鱼类群落的深度依赖性分区造成破坏

Richardson, Laura E; Heenan, Adel; Delargy, Adam J; Neubauer, Philipp; Lecky, Joey; Gove, Jamison M; Green, J A Mattias; Kindinger, Tye L; Ingeman, Kurt E; Williams, Gareth J

Emergent effects of global change on consumption depend on consumers and their resources in marine systems

全球变化对消费的涌现影响取决于海洋系统中的消费者及其资源。

Kindinger, Tye L; Toy, Jason A; Kroeker, Kristy J

Coral taxonomy and local stressors drive bleaching prevalence across the Hawaiian Archipelago in 2019

2019年,珊瑚分类和当地压力因素导致夏威夷群岛珊瑚白化现象普遍存在。

Winston, Morgan; Oliver, Thomas; Couch, Courtney; Donovan, Mary K; Asner, Gregory P; Conklin, Eric; Fuller, Kimberly; Grady, Bryant W; Huntington, Brittany; Kageyama, Kazuki; Kindinger, Tye L; Kozar, Kelly; Kramer, Lindsey; Martinez, Tatiana; McCutcheon, Amanda; McKenna, Sheila; Rodgers, Ku'ulei; Shayler, Cameron Kaʻilikea; Vargas-Angel, Bernardo; Zgliczynski, Brian

Hsf1 activation by proteotoxic stress requires concurrent protein synthesis

蛋白毒性应激激活 Hsf1 需要同时进行蛋白质合成

Blake W Tye, L Stirling Churchman

Circulating cytokines and monocyte subpopulations as biomarkers of outcome and biological activity in sunitinib-treated patients with advanced neuroendocrine tumours.

循环细胞因子和单核细胞亚群作为舒尼替尼治疗晚期神经内分泌肿瘤患者的疗效和生物活性的生物标志物

Zurita A J, Khajavi M, Wu H-K, Tye L, Huang X, Kulke M H, Lenz H-J, Meropol N J, Carley W, DePrimo S E, Lin E, Wang X, Harmon C S, Heymach J V

Evaluating Temporal Consistency in Marine Biodiversity Hotspots

评估海洋生物多样性热点地区的时间一致性

Piacenza, Susan E; Thurman, Lindsey L; Barner, Allison K; Benkwitt, Cassandra E; Boersma, Kate S; Cerny-Chipman, Elizabeth B; Ingeman, Kurt E; Kindinger, Tye L; Lindsley, Amy J; Nelson, Jake; Reimer, Jessica N; Rowe, Jennifer C; Shen, Chenchen; Thompson, Kevin A; Heppell, Selina S

Patterns and Variation in Benthic Biodiversity in a Large Marine Ecosystem

大型海洋生态系统底栖生物多样性的模式和变化

Piacenza, Susan E; Barner, Allison K; Benkwitt, Cassandra E; Boersma, Kate S; Cerny-Chipman, Elizabeth B; Ingeman, Kurt E; Kindinger, Tye L; Lee, Jonathan D; Lindsley, Amy J; Reimer, Jessica N; Rowe, Jennifer C; Shen, Chenchen; Thompson, Kevin A; Thurman, Lindsey L; Heppell, Selina S

A randomized, double-blind, phase II study of erlotinib with or without sunitinib for the second-line treatment of metastatic non-small-cell lung cancer (NSCLC).

一项随机、双盲、II 期研究,评估厄洛替尼联合或不联合舒尼替尼作为转移性非小细胞肺癌 (NSCLC) 二线治疗的疗效

Groen H J M, Socinski M A, Grossi F, Juhasz E, Gridelli C, Baas P, Butts C A, Chmielowska E, Usari T, Selaru P, Harmon C, Williams J A, Gao F, Tye L, Chao R C, Blumenschein G R Jr

A phase I dose-escalation and pharmacokinetic study of sunitinib in combination with pemetrexed in patients with advanced solid malignancies, with an expanded cohort in non-small cell lung cancer

一项舒尼替尼联合培美曲塞治疗晚期实体恶性肿瘤患者的 I 期剂量递增和药代动力学研究,并扩大了非小细胞肺癌患者的队列。

Chow, L Q M; Blais, N; Jonker, D J; Laurie, S A; Diab, S G; Canil, C; McWilliam, M; Thall, A; Ruiz-Garcia, A; Zhang, K; Tye, L; Chao, R C; Camidge, D R